Selma Boulenouar
Faculty Harvard Medical School and Mass General Brigham
Seminars
Thursday 17th September 2026
Neuro-Immuno-Metabolic Regulation of MASH Progression
2:00 pm
- Investigating immune-mediated mechanisms underlying MASH progression to identify novel therapeutic intervention opportunities, enabling more targeted treatment strategies and improving disease modification potential
- Evaluating emerging immunomodulatory approaches in preclinical models to influence key pathways associated with inflammation and fibrosis, strengthening mechanistic understanding and expanding future therapeutic possibilities
- Leveraging preclinical insights to support the development of precision medicine strategies that address diverse disease drivers, improving translational relevance and maximizing long-term patient benefit
